May 6, 2024 – Talk Bio

Actionable Insights Powered by AI

Johnson & Johnson Presents Updated Findings on Balversa Treatment for Bladder Cancer

12 months ago talkbio0Tagged Balversa, Carcinoma, Transitional Cell, Clinical Data, Fibroblast Growth Factor Receptors, Inhibitor, Johnson and Johnson, Malignant neoplasm of urinary bladder

Johnson & Johnson, Balversa, bladder cancer, clinical data, FGFR inhibitor, targeted therapy, urothelial carcinoma.

CG Oncology’s Immunotherapy Shows Promising Complete Response Rate in Bladder Cancer Patients

12 months ago talkbio0Tagged Cancer Therapeutic Procedure, centigram, Clinical Trials, Immunotherapy, Malignant neoplasm of urinary bladder, Neoplasms

CG Oncology, immunotherapy, bladder cancer, complete response rate, clinical trials, cancer treatment.